Turner v Bayer Australia Ltd (No 3)

Link copied
Case Copied 39 min read
IN THE SUPREME COURT OF VICTORIA Not Restricted

AT MELBOURNE

COMMON LAW DIVISION

GROUP PROCEEDINGS LIST

S ECI 2019 02916

PATRICE SARAH TURNER Plaintiff
v 
BAYER AUSTRALIA LTD (ACN 000 138 714) & ORS Defendants

---

JUDGE:

KEOGH J

WHERE HELD:

Melbourne

DATE OF HEARING:

6 February 2023

DATE OF RULING:

24 February 2023

CASE MAY BE CITED AS:

Turner v Bayer Australia Ltd (No 3)

MEDIUM NEUTRAL CITATION:

[2023] VSC 71 (First revision 6 November 2023)

---

PRACTICE AND PROCEDURE — Pleadings — Further and better particulars — Leave to amend — Supreme Court (General Civil Procedure) Rules2005 (Vic), r 36.04(1).

---

APPEARANCES:

Counsel Solicitors
For the Plaintiff F Forsyth KC with E Levine Slater & Gordon
For the First to Fourth and Sixth Defendants D Collins KC with D Wong Clayton Utz
For the Fifth Defendant N Connell (as solicitor) Mills Oakley

HIS HONOUR:

  1. This representative proceeding is a product liability action concerning implanted permanent contraceptive medical devices identified collectively as the Essure device.  The plaintiff brings the proceeding on behalf of all women who have had an Essure device implanted and suffered harm as a result.  She claims damages for breach of the Australian Consumer Law[1] (‘ACL’) and Trade Practices Act 1974 (Cth) (‘TPA’), and in negligence based on allegations of defective design and failure to warn.   

    [1]Competition and Consumer Act 2010 (Cth), Schedule 2.

  1. The proceeding is listed for trial on an estimate of 12 weeks commencing on 11 April 2023.

  1. In December 2022, the plaintiff filed and served further and better particulars of her amended statement of claim (‘ASOC’). 

  1. The first to fourth and sixth defendants (‘Bayer and AMSL defendants’) oppose the plaintiff being granted leave to amend her pleading in accordance with some of the further and better particulars on grounds that the proposal to amend comes at a late stage in the proceeding and without satisfactory explanation, and because the impugned particulars represent an expansion of the plaintiff’s case, and will cause substantial delay and give rise to wasted costs.  They submitted that if any of the impugned further particulars were allowed, they should have the opportunity to file and serve further evidence responding to the new allegations.

Statement of claim

  1. Relevant features of the Essure device are pleaded in the ASOC as follows:

14.The Essure Device was comprised of:

a.a micro-insert;

b.a disposable delivery system; and

c.a disposable introducer.

15.The micro-insert in the Essure Device (the Essure Insert):

a.was comprised of:

i)a 316L stainless steel inner coil (the Inner Coil);

ii)a chromium-doped nitinol (nickel-titanium alloy) outer coil (the Outer Coil);

iii)polyethylene terephthalate (PET) fibres;

iv)platinum-iridium bands and bump;

v)silver-tin solder;

b.was a spring-like device;

c.was wound down such that it was approximately 4cm in length and 0.8mm in diameter;

d.expanded up to approximately 2.0 mm in diameter when released;

e.figure 1a (below), obtained from the 2014 Essure Clinical Resource Physician Training Manual, is a depiction (not to…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Turner v Bayer Australia Ltd (No 3) and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2023] VSC 71
Decision Date

CaseChat Overview and Summary

The matter before the court involved Turner, a plaintiff, and Bayer Australia Ltd, a defendant, in the Supreme Court of Victoria. The dispute centred on the plaintiff's application for leave to amend his statement of claim, seeking to add further particulars in relation to the defendant's liability for damages arising from the alleged negligence in the manufacturing and marketing of a pharmaceutical product. The court was tasked with determining whether the plaintiff should be granted leave to amend his pleadings to include additional details.

The legal issue before the court was whether the plaintiff's proposed amendments would sufficiently particularise the plaintiff's claims, and whether the grant of leave to amend would be in the interests of justice. The plaintiff argued that the additional particulars were necessary to establish the basis of the defendant's liability, while the defendant contended that the amendments were futile and would not provide any new or relevant information. The court had to weigh the importance of allowing parties to fully ventilate their claims against the potential for unnecessary delay and prejudice to the opposing party.

The court found that the proposed amendments would indeed provide further particulars that were necessary for the plaintiff to establish his case. The court considered that the additional details would assist in clarifying the specific allegations against the defendant and the basis of the plaintiff's claims. The court further found that granting leave to amend would not result in any significant prejudice to the defendant and would be in the interests of justice. Consequently, the court granted the plaintiff leave to amend his statement of claim to include the further particulars sought.

The court ordered that the plaintiff be granted leave to amend his statement of claim to include the proposed further particulars, with the condition that the amendments be made within a specified timeframe. The court also noted that any further applications for amendments would be subject to the court's discretion and would need to demonstrate a proper basis for the additional particulars sought.

Orders

Orders of the court

Full text does not contain this section.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.